Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ophir

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The Journal of General Virology|September 5, 2023
The CD46 ectodomain participates in human cytomegalovirus infection of epithelial cellsAndrea J Parsons, Kathryn R Stein, Kristina E Atanasoff, et al.
Antiviral Research|July 1, 2021
Valspodar limits human cytomegalovirus infection and disseminationAndrea J Parsons, Tobias Cohen, Toni M Schwarz, et al.
Communications Biology|April 26, 2022
Development of broadly neutralizing antibodies targeting the cytomegalovirus subdominant antigen gHAndrea J Parsons, Sabrina I Ophir, J Andrew Duty, et al.
Journal of Virology|June 4, 2024
A broadly neutralizing human monoclonal antibody generated from transgenic mice immunized with HCMV particles limits virus infection and proliferationKristina E Atanasoff, Andrea J Parsons, Sabrina I Ophir, et al.
Antiviral Research|November 28, 2024
N-arylpyrimidinamine (NAPA) compounds are broadly acting inhibitors of human cytomegalovirus infection and spreadKristina E Atanasoff, Sabrina I Ophir, Andrea J Parsons, et al.
Antiviral Research|December 13, 2022
Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirusAndrea J Parsons, Sabrina I Ophir, Thomas J Gardner, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The Journal of General Virology|September 5, 2023
The CD46 ectodomain participates in human cytomegalovirus infection of epithelial cellsAndrea J Parsons, Kathryn R Stein, Kristina E Atanasoff, et al.
Antiviral Research|July 1, 2021
Valspodar limits human cytomegalovirus infection and disseminationAndrea J Parsons, Tobias Cohen, Toni M Schwarz, et al.
Communications Biology|April 26, 2022
Development of broadly neutralizing antibodies targeting the cytomegalovirus subdominant antigen gHAndrea J Parsons, Sabrina I Ophir, J Andrew Duty, et al.
Journal of Virology|June 4, 2024
A broadly neutralizing human monoclonal antibody generated from transgenic mice immunized with HCMV particles limits virus infection and proliferationKristina E Atanasoff, Andrea J Parsons, Sabrina I Ophir, et al.
Antiviral Research|November 28, 2024
N-arylpyrimidinamine (NAPA) compounds are broadly acting inhibitors of human cytomegalovirus infection and spreadKristina E Atanasoff, Sabrina I Ophir, Andrea J Parsons, et al.
Antiviral Research|December 13, 2022
Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirusAndrea J Parsons, Sabrina I Ophir, Thomas J Gardner, et al.
Pageof 3